Outcomes of antifungal prophylaxis in high-risk haematological patients (aml under intensive chemotherapy): the saphir prospective multicentre study

HIGHLIGHTS

• who: Jean-Pierre Gangneux and collaborators from the Mycology, Centre Hospitalier Universitaire Rennes, University Rennes, INSERM, (Institut Recherche en Santé, Environnement et Travail), UMR S_1085, Rennes, France have published the article: Outcomes of Antifungal Prophylaxis in High-Risk Haematological Patients (AML under Intensive Chemotherapy): The SAPHIR Prospective Multicentre Study, in the Journal: (JOURNAL) of 30/Dec/2015
• what: This study aimed to provide an extensive, diagnostic and therapeutic description of patients at high risk of IFD under AFP in French haematological services to evaluate outcomes and potential benefits. The initial AFP treatment and the modifications . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.